Home

VeriTeQ'S advanced Technology Helps Device Manufacturers, Physicians and Patients

VeriTeQ develops innovative, FDA cleared, radio frequency identification (RFID) solutions to identify implantable medical devices, FDA cleared radiation dose measurement technologies, and future bio-sensing applications.

RECENT FDA DRAFT GUIDANCE NAMES RFID AS A TECHNOLOGY SOLUTION FOR DIRECT PART MARKING

VeriTeQ’s Q Inside Safety Technology meets the direct part marking requirement of the FDA’s final rule as an RFID microtransponder…
Read Article

Most Recent

Jul 28th

VeriTeQ Corporation Announces Reverse Stock Split

Company to trade as VTEQD for 20 trading days DELRAY…
Read Article

Jun 02nd

More than 10,000 Women Have Received Motiva Breast…

Adoption of Q Inside Safety Technology Continues to Expand Across…
Read Article

May 21st

VeriTeQ Awarded New U.S. Patent for Wireless Molecular…

Patent to be used in development of bio-sensing microchip applications…
Read Article

May 15th

VeriTeQ Receives $100,000 Purchase Order for its Q…

DELRAY BEACH, FL – May 15, 2015 –VeriTeQ Corporation (“VeriTeQ”…
Read Article

Apr 23rd

VeriTeQ’s Chairman and CEO, Scott R. Silverman, and…

DELRAY BEACH, FL – April 23, 2015 – VeriTeQ Corporation…
Read Article

Apr 16th

VeriTeQ Files its 10-K and Announces 2014 Highlights

VeriTeQ commercially launched its Q Inside Safety Technology and delivered…
Read Article